Latest filing published 03 Apr 2024 for Metagenomi, Inc..
Insider track record
Luis Borges: trading record in brief
This profile gathers the share dealings of Luis Borges across 3 companies, led by Century Therapeutics, Inc., Five Prime Therapeutics Inc and Metagenomi Therapeutics, Inc. In total, 15 filings cover trades dated from 8 September 2016 to 1 April 2024.
The open-market record consists of 3 sales worth €502k, with no purchase. Besides market trades, the filings include 8 share grants and 4 option exercises.
On 3 April 2024 came the latest disclosure, a share grant in Metagenomi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Luis Borges
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 69,316 shares0Common StockSEC:0000950170-24-041551:0
- 7,452 shares@ US$1.0310.3% of flowCommon StockSEC:0001062993-23-008770:0
- 63,616 shares@ US$1.0389.7% of flowCommon StockSEC:0001062993-23-007574:0
- 21,875 shares0Common StockSEC:0001062993-23-002309:0
4 of 4 declarations
